FDA launches crowdsourcing challenge to solicit input on research questions to be addressed through FDA's oncologic clinical trial data

FDA

18 May 2021 - Today, the U.S. FDA's Oncology Center of Excellence launched the “Send Your Oncology Research Questions to FDA” crowdsourcing challenge. 

The Oncology Center of Excellence is using this challenge to provide an opportunity for interested stakeholders to submit ideas for research using pooled analyses of oncologic clinical trial data directly to FDA’s scientific staff.

Traditionally, FDA’s scientists have used pooled analyses to deepen understanding of efficacy of approved drugs, investigate relationships between different clinical endpoints used in regulatory submissions, and explore the potential for external controls to provide context for single arm trials.

Read FDA News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , Clinical trial